Literature DB >> 21632085

Severe canine influenza in dogs correlates with hyperchemokinemia and high viral load.

Yu-Na Lee1, Hyun-Jeong Lee, Dong-Hun Lee, Jung-Hyun Kim, Hee-Myung Park, Sang-Soep Nahm, Joong-Bok Lee, Seung-Yong Park, In-Soo Choi, Chang-Seon Song.   

Abstract

Canine influenza virus (CIV) is an emerging pathogen that causes acute respiratory disease in dogs. To better understand the mechanism(s) responsible for the virulence of the virus, we conducted immunological, virological, clinical, and histopathological analyses in CIV-infected dogs. CIV replicated efficiently in the respiratory system of dogs and caused severe respiratory disease. Notably, the infection induced the marked elevation and sustained expression of chemokines that resulted in severe bronchointerstitial pneumonia with extensive neutrophil infiltration. In clinicopathological findings, CIV infection resulted in regenerative anemia, perhaps due to pulmonary hemorrhage. The observations indicate that active replication of CIV in the canine respiratory system results in intense inflammatory responses central to the pathogenesis of H3N2 CIV.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632085     DOI: 10.1016/j.virol.2011.05.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Complete genome sequence of an H3N2 canine influenza virus from dogs in Jiangsu, China.

Authors:  Yan Lin; Yan-Bing Zhao; Xu-Jian Zeng; Cheng-Ping Lu; Yong-Jie Liu
Journal:  J Virol       Date:  2012-10       Impact factor: 5.103

2.  A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.

Authors:  Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Andrew T Gewirtz; Sang-Moo Kang
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

3.  Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.

Authors:  Yu-Na Lee; Min-Chul Kim; Young-Tae Lee; Yu-Jin Kim; Jongsang Lee; Cheol Kim; Suk-Hoon Ha; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2015-08-04       Impact factor: 5.970

4.  Monoclonal antibody specific to HA2 glycopeptide protects mice from H3N2 influenza virus infection.

Authors:  Xing Xie; Yan Lin; Maoda Pang; Yanbing Zhao; Dildar Hussain Kalhoro; Chengping Lu; Yongjie Liu
Journal:  Vet Res       Date:  2015-03-19       Impact factor: 3.683

5.  Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.

Authors:  Yu-Na Lee; Min-Chul Kim; Young-Tae Lee; Hye Suk Hwang; Jongsang Lee; Cheol Kim; Sang-Moo Kang
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 6.  Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use.

Authors:  Dong-Hun Lee; Jae-Keun Park; Chang-Seon Song
Journal:  Clin Exp Vaccine Res       Date:  2014-06-20

7.  Canine influenza virus coinfection with Staphylococcus pseudintermedius enhances bacterial colonization, virus load and clinical presentation in mice.

Authors:  Dildar Hussain Kalhoro; Shanshan Gao; Xing Xie; Shan Liang; Su Luo; Yanbing Zhao; Yongjie Liu
Journal:  BMC Vet Res       Date:  2016-06-04       Impact factor: 2.741

8.  Pathology of Equine Influenza virus (H3N8) in Murine Model.

Authors:  Selvaraj Pavulraj; Bidhan Chandra Bera; Alok Joshi; Taruna Anand; Meenakshi Virmani; Rajesh Kumar Vaid; Karuppusamy Shanmugasundaram; Baldev Raj Gulati; K Rajukumar; Rajendra Singh; Jyoti Misri; Raj Kumar Singh; Bhupendra Nath Tripathi; Nitin Virmani
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.